Publication:
Poisoning of butanol-containing products: Clinical characteristics and outcomes

dc.contributor.authorSatariya Trakulsrichaien_US
dc.contributor.authorNitchakarn Boonyoken_US
dc.contributor.authorPhantakan Tansuwannaraten_US
dc.contributor.authorCharuwan Sriaphaen_US
dc.contributor.authorWinai Wananukulen_US
dc.contributor.otherFaculty of Medicine Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherMaharaj Nakhon Si Thammarat Hospitalen_US
dc.date.accessioned2022-08-04T11:05:58Z
dc.date.available2022-08-04T11:05:58Z
dc.date.issued2021-01-01en_US
dc.description.abstractBackground: Butanol (butyl alcohol) is a chemical which occurs naturally in some foods and is used in the manufacture of other chemicals. Current data on butanol poisoning in humans are limited. Objective: This study describes clinical characteristics and outcomes of patients exposed to products containing butanol. Methods: We performed a 5-year retrospective cross-sectional study by analyzing data from the Ramathibodi Poison Center Toxic Exposure Surveillance System for 2013–2017. Results: There were 163 patients included in the study. All products containing butanol reported were agricultural adjuvant products. Most (67.5%) patients were males and had ingested butanol accidentally (75.5%). The median age was 42 years. Almost all patients had oral exposure to butanol. At presentation, most of our patients had normal vital signs and were conscious. Clinical presentations mostly included gastrointestinal symptoms (65%) and local irritation (28.8%). Fifty-four patients (33.1%) had no obvious clinical effects at presentation. Most patients had normal laboratory tests at presentation, although eight developed systemic effects including high anion gap metabolic acidosis (n=8), acute kidney injury (AKI; n=5), depression of consciousness (n=5), and hypotension (n=3). Of these eight patients, two with intentional ingestion developed altered consciousness, hypotension, AKI, severe metabolic acidosis, and eventually died. One of these died within 1 day after ingestion, while the other died later through complications during admission. Therefore, the mortality rate was 1.23%. Sixty-six patients (40.5%) were admitted to hospitals, with a median length of stay of 1 day. Most patients received only supportive treatment and fully recovered. Conclusion: Agricultural adjuvant products containing butanol or butanol itself caused only mild effects in most patients, but systemic effects occurred in some. The mortality from this poisoning was very low, and both fatalities were from intentional ingestion. Supportive care and proper management of complications should be the main treatment for this form of poisoning.en_US
dc.identifier.citationInternational Journal of General Medicine. Vol.14, (2021), 6001-6008en_US
dc.identifier.doi10.2147/IJGM.S325398en_US
dc.identifier.issn11787074en_US
dc.identifier.other2-s2.0-85115797847en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/78605
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85115797847&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePoisoning of butanol-containing products: Clinical characteristics and outcomesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85115797847&origin=inwarden_US

Files

Collections